Willem Mulder is a professor of Precision Medicine at the Radboud University Medical Center and the Eindhoven University of Technology. His research focuses on developing nanomedicine-based therapies against immune-mediated diseases. Willem Mulder is co-founder and CSO of Trained Therapeutix and co-founder and CTO of BioTrip, biotech companies focusing on translating immunotherapy.
www.mulderlab.com
https://ttxdiscovery.com
https://biotrip.nl
Disclosure information not submitted.
Plenary Duet I Nanomedicines, Antibodies and Imaging for Cancer Therapy
Tuesday, July 9, 2024
12:00 PM – 1:30 PM CET
